 PAVmed Inc. Nasdaq: PAVM, PAVMZ the Company or PAVmed, a highly differentiated, multiproduct medical device company, today announced it has added the EsoCureTM Esophageal Ablation Device with CaldusTM Technology to its commercial product pipeline. EsoCures disposable single-use thermal balloon ablation catheter is designed to advance through the working channel of a standard endoscope and allow the clinician to treat dysplastic Barretts Esophagus BE before it can progress to highly lethal esophageal cancer EAC and to do so without the need for complex and expensive capital equipment. 